EYETHENA

A Revolutionary DTx Solution for Glaucoma

Eyethena is the first ever, patented digital therapeutic solution for the early detection, preventive management and treatment of glaucoma.

Eyethena Transforms Treatment

Eyethena transforms glaucoma disease treatment for practitioners and patients alike. Eyethena enables continuous monitoring for changes in eye health, and helps increase patient compliance with treatment protocols for better results. Patients benefit from personalized emotional and lifestyle guidance to support their overall health and well-being throughout all stages of glaucoma treatment.

The powerful Eyethena technology is delivered to patients in an intuitively-designed, easy-to-use mobile app that they can access anytime from their mobile phones — it’s like having their own eye health expert right in their pocket.

Eyethena supports patients

The Eyethena app gives patients everything they need to follow their practitioner’s treatment guidelines and recommendations on a daily basis. With Eyethena patients can record important eye health metrics, more consistently follow medication recommendations, and receive health and lifestyle guidance that may improve their chances of slowing disease progression and preventing vision loss and blindness.

Eyethena Empowers Ophthalmologists

For ophthalmologists, the Eyethena app drastically improves the ability to effectively work with patients — simultaneously simplifying the delivery and communication of treatment protocols while providing unprecedented clinical insight into patient eye health and disease condition.

Eyethena provides BETTER data

With Eyethena, eye health practitioners gain access to better and more consistent patient clinical data, including physical, psychological and lifestyle factors that may impede or improve glaucoma treatment. More robust patient data leads to better insight into a patient’s eye health, and helps practitioners to deliver a more personalized approach to glaucoma treatment that may lead to better outcomes for their patients.